BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 22912641)

  • 1. Duffy antigen receptor for chemokines and its involvement in patterning and control of inflammatory chemokines.
    Novitzky-Basso I; Rot A
    Front Immunol; 2012; 3():266. PubMed ID: 22912641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of Duffy antigen to chemokine function.
    Rot A
    Cytokine Growth Factor Rev; 2005 Dec; 16(6):687-94. PubMed ID: 16054417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Duffy antigen/receptor for chemokines (DARC) is expressed in endothelial cells of Duffy negative individuals who lack the erythrocyte receptor.
    Peiper SC; Wang ZX; Neote K; Martin AW; Showell HJ; Conklyn MJ; Ogborne K; Hadley TJ; Lu ZH; Hesselgesser J; Horuk R
    J Exp Med; 1995 Apr; 181(4):1311-7. PubMed ID: 7699323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duffy antigen receptor for chemokines mediates chemokine endocytosis through a macropinocytosis-like process in endothelial cells.
    Zhao Y; Mangalmurti NS; Xiong Z; Prakash B; Guo F; Stolz DB; Lee JS
    PLoS One; 2011; 6(12):e29624. PubMed ID: 22216333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Duffy antigen receptor for chemokines transports chemokines and supports their promigratory activity.
    Pruenster M; Mudde L; Bombosi P; Dimitrova S; Zsak M; Middleton J; Richmond A; Graham GJ; Segerer S; Nibbs RJ; Rot A
    Nat Immunol; 2009 Jan; 10(1):101-8. PubMed ID: 19060902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of erythrocyte Duffy antigen genetic polymorphism on the distribution of GroBeta-T, a novel human CXC chemokine.
    Hepburn TW; Tobia LP; Shi W; McIntyre TA; Davis CB
    J Pharm Pharm Sci; 2007; 10(4):486-95. PubMed ID: 18396564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A high endothelial venule-expressing promiscuous chemokine receptor DARC can bind inflammatory, but not lymphoid, chemokines and is dispensable for lymphocyte homing under physiological conditions.
    Kashiwazaki M; Tanaka T; Kanda H; Ebisuno Y; Izawa D; Fukuma N; Akimitsu N; Sekimizu K; Monden M; Miyasaka M
    Int Immunol; 2003 Oct; 15(10):1219-27. PubMed ID: 13679391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct Transcript Isoforms of the Atypical Chemokine Receptor 1 (ACKR1)/Duffy Antigen Receptor for Chemokines (DARC) Gene Are Expressed in Lymphoblasts and Altered Isoform Levels Are Associated with Genetic Ancestry and the Duffy-Null Allele.
    Davis MB; Walens A; Hire R; Mumin K; Brown AM; Ford D; Howerth EW; Monteil M
    PLoS One; 2015; 10(10):e0140098. PubMed ID: 26473357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemokine homeostasis vs. chemokine presentation during severe acute lung injury: the other side of the Duffy antigen receptor for chemokines.
    Zarbock A; Bishop J; Müller H; Schmolke M; Buschmann K; Van Aken H; Singbartl K
    Am J Physiol Lung Cell Mol Physiol; 2010 Mar; 298(3):L462-71. PubMed ID: 20061440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Duffy antigen/receptor for chemokines (DARC) regulates prostate tumor growth.
    Shen H; Schuster R; Stringer KF; Waltz SE; Lentsch AB
    FASEB J; 2006 Jan; 20(1):59-64. PubMed ID: 16394268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Throwing light on DARC.
    Pruenster M; Rot A
    Biochem Soc Trans; 2006 Dec; 34(Pt 6):1005-8. PubMed ID: 17073738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythrocyte Duffy antigen receptor for chemokines (DARC): diagnostic and therapeutic implications in atherosclerotic cardiovascular disease.
    Apostolakis S; Chalikias GK; Tziakas DN; Konstantinides S
    Acta Pharmacol Sin; 2011 Apr; 32(4):417-24. PubMed ID: 21441947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Duffy antigen receptor for chemokines: structural analysis and expression in the brain.
    Horuk R; Martin A; Hesselgesser J; Hadley T; Lu ZH; Wang ZX; Peiper SC
    J Leukoc Biol; 1996 Jan; 59(1):29-38. PubMed ID: 8558064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duffy antigen/receptor for chemokines (DARC) attenuates angiogenesis by causing senescence in endothelial cells.
    Xu L; Ashkenazi A; Chaudhuri A
    Angiogenesis; 2007; 10(4):307-18. PubMed ID: 17955335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of the duffy antigen receptor for chemokines (DARC) by NSCLC tumor cells results in increased tumor necrosis.
    Addison CL; Belperio JA; Burdick MD; Strieter RM
    BMC Cancer; 2004 Jun; 4():28. PubMed ID: 15214968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DARC shuttles inflammatory chemokines across the blood-brain barrier during autoimmune central nervous system inflammation.
    Minten C; Alt C; Gentner M; Frei E; Deutsch U; Lyck R; Schaeren-Wiemers N; Rot A; Engelhardt B
    Brain; 2014 May; 137(Pt 5):1454-69. PubMed ID: 24625696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular Storage of Duffy Antigen-Binding Chemokines by Duffy-Positive Red Blood Cells.
    Yamamoto A; Saito N; Ogasawara S; Shiratori T; Kondo J; Itoga M; Kayaba H
    Clin Lab; 2017 Apr; 63(4):717-723. PubMed ID: 28397469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The promiscuous chemokine binding profile of the Duffy antigen/receptor for chemokines is primarily localized to sequences in the amino-terminal domain.
    Lu ZH; Wang ZX; Horuk R; Hesselgesser J; Lou YC; Hadley TJ; Peiper SC
    J Biol Chem; 1995 Nov; 270(44):26239-45. PubMed ID: 7592830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulphated tyrosines mediate association of chemokines and Plasmodium vivax Duffy binding protein with the Duffy antigen/receptor for chemokines (DARC).
    Choe H; Moore MJ; Owens CM; Wright PL; Vasilieva N; Li W; Singh AP; Shakri R; Chitnis CE; Farzan M
    Mol Microbiol; 2005 Mar; 55(5):1413-22. PubMed ID: 15720550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential Role of DARC-Chemokine Interaction in the Recruitment of Osteoclast Precursors in Response to Bacterial Lipopolysaccharide Challenge.
    Alemi F; Elgendy M; Edderkaoui B
    Calcif Tissue Int; 2016 Nov; 99(5):481-488. PubMed ID: 27376530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.